Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2

Dampalla, Chamandi S.; Zheng, Jian; Perera, Krishani Dinali; Wong, Lok-Yin Roy; Meyerholz, David K.; Nguyen, Harry Nhat; Kashipathy, Maithri M.; Battaile, Kevin P.; Lovell, Scott; Kim, Yunjeong; Perlman, Stanley; Groutas, William C.; Chang, Kyeong-Ok

doi:10.1073/pnas.2101555118

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2

Journal Article · 01 July 2021 · Proc. Natl. Acad. Sci. USA

DOI:https://doi.org/10.1073/pnas.2101555118· OSTI ID:1826764

Dampalla, Chamandi S.; Zheng, Jian; Perera, Krishani Dinali; Wong, Lok-Yin Roy; Meyerholz, David K.; Nguyen, Harry Nhat; Kashipathy, Maithri M.; Battaile, Kevin P.; Lovell, Scott; Kim, Yunjeong; Perlman, Stanley; Groutas, William C.; Chang, Kyeong-Ok

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; National Institutes of Health (NIH)

OSTI ID:: 1826764

Journal Information:: Proc. Natl. Acad. Sci. USA, Vol. 118, Issue (29)

Country of Publication:: United States

Language:: ENGLISH

References (56)

Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2 No authors listed Future Medicinal Chemistry https://doi.org/10.4155/fmc-2020-0158		September 2020
COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice No authors listed Nature https://doi.org/10.1038/s41586-020-2943-z		November 2020
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice No authors listed Cell Reports https://doi.org/10.1016/j.celrep.2020.107940		July 2020
A Mouse Model of SARS-CoV-2 Infection and Pathogenesis No authors listed Cell Host & Microbe https://doi.org/10.1016/j.chom.2020.05.020		July 2020
Lethal Infection of K18- hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus No authors listed Journal of Virology https://doi.org/10.1128/JVI.02012-06		January 2007
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication No authors listed Nature Communications https://doi.org/10.1038/s41467-020-18096-2		August 2020
Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. No authors listed Mendeley https://doi.org/10.17632/x3sw5z2bg9.1		January 2020
Developments in the CCP 4 molecular-graphics project No authors listed Acta Crystallographica Section D Biological Crystallography https://doi.org/10.1107/S0907444904023716		November 2004
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice No authors listed Nature https://doi.org/10.1038/s41586-020-2312-y		May 2020
Structure-Guided Design and Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease. Structure–Activity Relationships and Biochemical, X-ray Crystallographic, Cell-Based, and In Vivo Studies No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/jm5019934		March 2015
Design, Synthesis, and Evaluation of Novel Prodrugs of Transition State Inhibitors of Norovirus 3CL Protease No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.7b00497		July 2017
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication No authors listed Biological Magnetic Resonance Bank https://doi.org/10.13018/bmr50262		January 2020
Immunopathology of Hyperinflammation in COVID-19 No authors listed The American Journal of Pathology https://doi.org/10.1016/j.ajpath.2020.08.009		January 2021
Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses No authors listed Journal of Virology https://doi.org/10.1128/JVI.01348-12		August 2012
Towards automated crystallographic structure refinement with phenix.refine No authors listed Acta Crystallographica Section D Biological Crystallography https://doi.org/10.1107/S0907444912001308		March 2012
Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element No authors listed European Journal of Medicinal Chemistry https://doi.org/10.1016/j.ejmech.2018.03.004		April 2018
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19 No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.0c01063		October 2020
A new coronavirus associated with human respiratory disease in China No authors listed Nature https://doi.org/10.1038/s41586-020-2008-3		February 2020
A Novel, Nonaqueous Method for Regeneration of Aldehydes from Bisulfite Adducts No authors listed The Journal of Organic Chemistry https://doi.org/10.1021/jo990543v		July 1999
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records No authors listed The Lancet Psychiatry https://doi.org/10.1016/S2215-0366(21)00084-5		May 2021
Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis No authors listed SAGE Journals https://doi.org/10.25384/sage.c.7254498		January 2024
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model No authors listed Biochemical and Biophysical Research Communications https://doi.org/10.1016/j.bbrc.2021.03.096		May 2021
Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis No authors listed Journal of Feline Medicine and Surgery https://doi.org/10.1177/1098612X17729626		May 2017
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease No authors listed Nature Communications https://doi.org/10.1038/s41467-020-18233-x		September 2020
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2 No authors listed Cell https://doi.org/10.1016/j.cell.2020.05.027		July 2020
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures No authors listed Nature https://doi.org/10.1038/s41586-020-2708-8		August 2020
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease No authors listed Cell Research https://doi.org/10.1038/s41422-020-0356-z		June 2020
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease No authors listed Science https://doi.org/10.1126/science.abb4489		April 2020
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing No authors listed Zenodo https://doi.org/10.5281/zenodo.3779045		January 2020
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice No authors listed Science Translational Medicine https://doi.org/10.1126/scitranslmed.abc5332		August 2020
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice No authors listed Nature Communications https://doi.org/10.1038/s41467-020-19891-7		November 2020
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2 No authors listed Nature https://doi.org/10.1038/s41586-020-2423-5		June 2020
Remdesivir for the Treatment of Covid-19 — Final Report No authors listed New England Journal of Medicine https://doi.org/10.1056/NEJMoa2007764		November 2020
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 No authors listed New England Journal of Medicine https://doi.org/10.1056/NEJMoa2031994		March 2021
A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CL ^pro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19 No authors listed Journal of Virology https://doi.org/10.1128/JVI.01819-20		April 2021
Applications of Deuterium in Medicinal Chemistry No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.8b01808		January 2019
Broad-Spectrum Inhibitors against 3C-Like Proteases of Feline Coronaviruses and Feline Caliciviruses No authors listed Journal of Virology https://doi.org/10.1128/JVI.03688-14		February 2015
The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract No authors listed Emerging Microbes & Infections https://doi.org/10.1080/22221751.2021.1899770		January 2021
MolProbity : all-atom structure validation for macromolecular crystallography No authors listed Acta Crystallographica Section D Biological Crystallography https://doi.org/10.1107/S0907444909042073		December 2009
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice No authors listed Science Translational Medicine https://doi.org/10.1126/scitranslmed.abb5883		April 2020
Features and development of Coot No authors listed Acta Crystallographica Section D Biological Crystallography https://doi.org/10.1107/S0907444910007493		March 2010
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing No authors listed Proceedings of the National Academy of Sciences https://doi.org/10.1073/pnas.2025866118		March 2021
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function No authors listed Nature Immunology https://doi.org/10.1038/s41590-020-0778-2		August 2020
An introduction to data reduction: space-group determination, scaling and intensity statistics No authors listed Acta Crystallographica Section D Biological Crystallography https://doi.org/10.1107/S090744491003982X		March 2011
Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P ₁ Lactam Moieties as l -Glutamine Replacements No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/jm9805384		April 1999
Structure-based exploration and exploitation of the S4 subsite of norovirus 3CL protease in the design of potent and permeable inhibitors No authors listed European Journal of Medicinal Chemistry https://doi.org/10.1016/j.ejmech.2016.11.027		January 2017
Tackling SARS-CoV-2: proposed targets and repurposed drugs No authors listed Future Medicinal Chemistry https://doi.org/10.4155/fmc-2020-0147		September 2020
SARS-CoV-2 M ^pro inhibitors with antiviral activity in a transgenic mouse model No authors listed Science https://doi.org/10.1126/science.abf1611		February 2021
Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs: Mechanism of Action, Clinical Development, Synthesis at Scale, and Outlook for Supply No authors listed Organic Process Research & Development https://doi.org/10.1021/acs.oprd.0c00233		June 2020
Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor No authors listed PLOS Pathogens https://doi.org/10.1371/journal.ppat.1005531		March 2016
Data processing and analysis with the autoPROC toolbox No authors listed Acta Crystallographica Section D Biological Crystallography https://doi.org/10.1107/S0907444911007773		March 2011
A review on drug repurposing applicable to COVID-19 No authors listed Briefings in Bioinformatics https://doi.org/10.1093/bib/bbaa288		November 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial No authors listed The Lancet https://doi.org/10.1016/S0140-6736(20)31022-9		May 2020
Phaser crystallographic software No authors listed Journal of Applied Crystallography https://doi.org/10.1107/S0021889807021206		July 2007
Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2 No authors listed British Journal of Pharmacology https://doi.org/10.1111/bph.15092		June 2020
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results No authors listed New England Journal of Medicine https://doi.org/10.1056/NEJMoa2023184		February 2021

Similar Records

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

Journal Article · 2021 · Proceedings of the National Academy of Sciences of the United States of America · OSTI ID:1816161

Dampalla, Chamandi S.; Zheng, Jian; Perera, Krishani Dinali; +10 more

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

Journal Article · 2022 · Proceedings of the National Academy of Sciences of the United States of America · OSTI ID:1809009

Dampalla, C; Zheng, J.; Perera, K.; +10 more

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2

Citation Formats

References (56)

Similar Records

Related Subjects